Affinity Asset Advisors’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-250,000
Closed -$2.63M 105
2024
Q4
$2.63M Hold
250,000
0.35% 48
2024
Q3
$2.61M Hold
250,000
0.36% 52
2024
Q2
$2.56M Hold
250,000
0.29% 57
2024
Q1
$2.59M Buy
+250,000
New +$2.59M 0.32% 56